 |
Tesevatinib |
|---|---|
| Trade Name | |
| Orphan Indication | Autosomal recessive polycystic kidney disease |
| USA Market Approval | USA |
| USA Designation Date | 2016-03-01 00:00:00 |
| Sponsor | Kadmon Corporation, LLC;450 East 29th Street;New York, New York, 10016 |
| |
Tesevatinib |
|---|---|
| Trade Name | |
| Orphan Indication | Autosomal recessive polycystic kidney disease |
| USA Market Approval | USA |
| USA Designation Date | 2016-03-01 00:00:00 |
| Sponsor | Kadmon Corporation, LLC;450 East 29th Street;New York, New York, 10016 |